OXIDIZED-LDL/β2-GLYCOPROTEIN I COMPLEXES AND ANTIPHOSPHOLIPID ANTIBODIES ARE ASSOCIATED WITH DISEASE SEVERITY AND RISK FOR ADVERSE OUTCOMES IN ACUTE CORONARY SYNDROME

被引：0
|
作者：
Lopez, L. [1 ]
Greco, T.
Conti-Kelly, A. M.
Anthony, R. [2 ]
Geske, J. [1 ]
Boisen, M. [1 ]
Matsuura, E. [3 ]
机构：
[1] Corgenix Inc, Broomfield, CO USA
[2] St Marys Hosp, Waterbury, CT USA
[3] Okayama Univ, Grad Sch Med, Okayama, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70187-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P120
引用
下载
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] Oxidized-LDL/β2-Glycoprotein I Complexes Are Associated With Disease Severity and Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndromes
    Greco, Thomas P.
    Conti-Kelly, Ann Marie
    Anthony, J. Robert
    Greco, Thomas, Jr.
    Doyle, Robin
    Boisen, Matt
    Kojima, Kazuo
    Matsuura, Eiji
    Lopez, Luis R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (05) : 737 - 743
  • [2] Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism
    Pengo, V.
    Bison, E.
    Ruffatti, A.
    Iliceto, S.
    THROMBOSIS RESEARCH, 2008, 122 (04) : 556 - 559
  • [3] PRO-ATHEROGENIC OXIDIZED-LDL/B2-GLYCOPROTEIN I COMPLEXES IN CORONARY ARTERY DISEASE PATIENTS ARE ASSOCIATED WITH DISEASE SEVERITY
    Lopez, L. R.
    Bliden, K. P.
    Chaudhary, R.
    Damrongwatanasuk, R.
    Guyer, K. E.
    Gesheff, M. G.
    Franzese, C. J.
    Tantry, U. S.
    Gurbel, P. A.
    ATHEROSCLEROSIS, 2016, 252 : E219 - E219
  • [4] Atherogenic autoantigen:: oxidized LDL complexes with β2-glycoprotein I
    Matsuura, E
    Kobayashi, K
    Koike, T
    Shoenfeld, Y
    Khamashta, MA
    Hughes, GRV
    IMMUNOBIOLOGY, 2003, 207 (01) : 17 - 22
  • [5] Antibodies to β2-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
    J Zabek
    S Luft
    T Reshetniak
    Z Alekberowa
    B Wojciechowska
    W Karlik
    V Nasonowa
    Arthritis Research & Therapy, 3
  • [6] Antibodies to β2-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
    Zabek, J.
    Luft, S.
    Reshetniak, T.
    Alekberowa, Z.
    Wojciechowska, B.
    Karlik, W.
    Nasonowa, V.
    ARTHRITIS RESEARCH & THERAPY, 2001, 3 (Suppl 2)
  • [7] Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease
    Bliden, Kevin P.
    Chaudhary, Rahul
    Lopez, Luis R.
    Damrongwatanasuk, Rongras
    Guyer, Kirk
    Gesheff, Martin G.
    Franzese, Christopher J.
    Kaza, Himabindu
    Tantry, Udaya S.
    Gurbel, Paul A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (05): : 673 - 678
  • [8] Oxidized LDL/β2-glycoprotein I complexes:: new aspects in atherosclerosis
    Matsuura, E
    Kobayashi, K
    Inoue, K
    Lopez, LR
    Shoenfeld, Y
    LUPUS, 2005, 14 (09) : 736 - 741
  • [9] Anti-β2-glycoprotein I antibodies and the antiphospholipid syndrome
    Li, Z
    Krilis, SA
    AUTOIMMUNITY REVIEWS, 2003, 2 (05) : 229 - 234
  • [10] Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome
    Cousins, Laura
    Pericleous, Charis
    Khamashta, Munther
    Bertolaccini, Maria Laura
    Ioannou, Yiannis
    Giles, Ian
    Rahman, Anisur
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 317 - U444
12345